Europe Neuromodulation Market Size, Share & Industry Trends Analysis Report By Technology (Internal and External), By Biomaterial, By Application, By Country and Growth Forecast, 2022 - 2028

The Europe Neuromodulation Market would witness Market growth of 5.8% CAGR during the forecast period (2022-2028).

Prominent manufacturers have strengthened their neurostimulation device research and development operations, resulting in a spike in the neuromodulation Market 's growth. Currently, a significant number of novel technologies are undergoing clinical trials. Key players are also collaborating on the development of cutting-edge neuromodulation technology. For example, LivaNova PLC, a Market -leading medical technology and innovation business, partnered with Verily in February 2020 to acquire fresh insights into the impact of Vagus Nerve Stimulation on difficult-to-treat depression. In addition, the Market is growing due to an increase in major players and new product launches in developing countries. Furthermore, Medtronic, a multinational medical device company, announced the launch of 'Percept PC' in India in July 2021, which is the first deep brain stimulation (DBS) system with BrainSense technology for movement disorders like epilepsy and Parkinson's.

Rising awareness of neurodegenerative and neurological illnesses are projected to benefit the Market . The increased prevalence of depression and its symptoms, particularly among millennials, creates new possibilities. Furthermore, Market growth is aided by increased knowledge of the efficacy and safety of neurostimulator devices.

As per the European Academy of Neurology (EAN), the prevalence of neurological illnesses in European countries is roughly 307,859,199. They're linked to a high risk of negative health consequences like death, disability, institutionalization, and hospitalization. Neurological illnesses in senior adults usually include degenerative diseases such as dementia and Parkinson's disease, as well as strokes and headaches. In 2018, Europe had the second-largest proportion of the Market . The need for non-invasive devices is being fueled by well-developed healthcare infrastructure and an increase in non-invasive device approvals in the region. During 2017-2018, new entrants and regional players got CE mark approvals for their non-invasive devices.

The Germany Market dominated the Europe Neuromodulation Market by Country in 2021, and would continue to be a dominant Market till 2028; thereby, achieving a Market value of $256.8 million by 2028. The UK Market is anticipated to grow at a CAGR of 4.9% during (2022 - 2028). Additionally, The France Market would display a CAGR of 6.6% during (2022 - 2028).

Based on Technology, the Market is segmented into Internal and External. Based on Biomaterial, the Market is segmented into Metallic, Polymeric, and Ceramic. Based on Application, the Market is segmented into Chronic Pain, Urinary & Fecal Incontinence, Migraine, Failed Back Syndrome, Parkinson Disease, Epilepsy, Tremor, Depression, and Others. Based on countries, the Market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

Free Valuable Insights: The Global Neuromodulation Market Size will Hit $3.8 Billion by 2028, at a CAGR of 6%

The Market research report covers the analysis of key stake holders of the Market . Key companies profiled in the report include Medtronic PLC, LivaNova PLC, Boston Scientific Corporation, Abbott Laboratories, Nevro Corporation, NeuroSigma, Inc., NeuroPace, Inc., Neuronetics, Inc., MicroTransponder Inc., and Bioventus Inc.

Scope of the Study

Market Segments Covered in the Report:

By Technology

• Internal
• External

By Biomaterial

• Metallic
• Polymeric
• Ceramic

By Application

• Chronic Pain
• Urinary & Fecal Incontinence
• Migraine
• Failed Back Syndrome
• Parkinson Disease
• Epilepsy
• Tremor
• Depression
• Others

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

• Medtronic PLC
• LivaNova PLC
• Boston Scientific Corporation
• Abbott Laboratories
• Nevro Corporation
• NeuroSigma, Inc.
• NeuroPace, Inc.
• Neuronetics, Inc.
• MicroTransponder Inc.
• Bioventus Inc.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Neuromodulation Market, by Technology
1.4.2 Europe Neuromodulation Market, by Biomaterial
1.4.3 Europe Neuromodulation Market, by Application
1.4.4 Europe Neuromodulation Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Approvals and Trials
3.2.3 Product Launches and Product Expansions
3.2.4 Acquisition and Mergers
3.2.5 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)

Chapter 4. Europe Neuromodulation Market by Technology
4.1 Europe Internal Market by Country
4.2 Europe External Market by Country

Chapter 5. Europe Neuromodulation Market by Biomaterial
5.1 Europe Metallic Market by Country
5.2 Europe Polymeric Market by Country
5.3 Europe Ceramic Market by Country

Chapter 6. Europe Neuromodulation Market by Application
6.1 Europe Chronic Pain Market by Country
6.2 Europe Urinary & Fecal Incontinence Market by Country
6.3 Europe Migraine Market by Country
6.4 Europe Failed Back Syndrome Market by Country
6.5 Europe Parkinson Disease Market by Country
6.6 Europe Epilepsy Market by Country
6.7 Europe Tremor Market by Country
6.8 Europe Depression Market by Country
6.9 Europe Others Market by Country

Chapter 7. Europe Neuromodulation Market by Country
7.1 Germany Neuromodulation Market
7.1.1 Germany Neuromodulation Market by Technology
7.1.2 Germany Neuromodulation Market by Biomaterial
7.1.3 Germany Neuromodulation Market by Application
7.2 UK Neuromodulation Market
7.2.1 UK Neuromodulation Market by Technology
7.2.2 UK Neuromodulation Market by Biomaterial
7.2.3 UK Neuromodulation Market by Application
7.3 France Neuromodulation Market
7.3.1 France Neuromodulation Market by Technology
7.3.2 France Neuromodulation Market by Biomaterial
7.3.3 France Neuromodulation Market by Application
7.4 Russia Neuromodulation Market
7.4.1 Russia Neuromodulation Market by Technology
7.4.2 Russia Neuromodulation Market by Biomaterial
7.4.3 Russia Neuromodulation Market by Application
7.5 Spain Neuromodulation Market
7.5.1 Spain Neuromodulation Market by Technology
7.5.2 Spain Neuromodulation Market by Biomaterial
7.5.3 Spain Neuromodulation Market by Application
7.6 Italy Neuromodulation Market
7.6.1 Italy Neuromodulation Market by Technology
7.6.2 Italy Neuromodulation Market by Biomaterial
7.6.3 Italy Neuromodulation Market by Application
7.7 Rest of Europe Neuromodulation Market
7.7.1 Rest of Europe Neuromodulation Market by Technology
7.7.2 Rest of Europe Neuromodulation Market by Biomaterial
7.7.3 Rest of Europe Neuromodulation Market by Application

Chapter 8. Company Profiles
8.1 Medtronic PLC
8.1.1 Company overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Product Launches and Product Expansions:
8.1.5.2 Acquisition and Mergers:
8.2 LivaNova PLC
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Approvals and Trials:
8.3 Boston Scientific Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Geographical Expansions:
8.4 Abbott Laboratories
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Product Launches and Product Expansions:
8.5 Nevro Corporation
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Approvals and Trials:
8.6 NeuroSigma, Inc.
8.6.1 Company Overview
8.6.2 Recent strategies and developments:
8.6.2.1 Partnerships, Collaborations, and Agreements:
8.7 NeuroPace, Inc.
8.7.1 Company Overview
8.7.2 Recent Strategies and Developments:
8.7.2.1 Product Launches and Product Expansions:
8.8 Neuronetics, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Regional Analysis
8.8.4 Research & Development Expense
8.9 MicroTransponder Inc.
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Approvals and Trials:
8.10. Bioventus Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 Recent strategies and developments:
8.10.5.1 Approvals and Trials:
8.10.5.2 Acquisition and Mergers:

TABLE 1 Europe Neuromodulation Market, 2018 - 2021, USD Million
TABLE 2 Europe Neuromodulation Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Neuromodulation Market
TABLE 4 Approvals and Trials - NEUROMODULATION MARKET
TABLE 5 Product Launches And Product Expansions– Neuromodulation Market
TABLE 6 Acquisition and Mergers– Neuromodulation Market
TABLE 7 Geographical Expansions- Neuromodulation Market
TABLE 8 Europe Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 9 Europe Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 10 Europe Internal Market by Country, 2018 - 2021, USD Million
TABLE 11 Europe Internal Market by Country, 2022 - 2028, USD Million
TABLE 12 Europe External Market by Country, 2018 - 2021, USD Million
TABLE 13 Europe External Market by Country, 2022 - 2028, USD Million
TABLE 14 Europe Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 15 Europe Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 16 Europe Metallic Market by Country, 2018 - 2021, USD Million
TABLE 17 Europe Metallic Market by Country, 2022 - 2028, USD Million
TABLE 18 Europe Polymeric Market by Country, 2018 - 2021, USD Million
TABLE 19 Europe Polymeric Market by Country, 2022 - 2028, USD Million
TABLE 20 Europe Ceramic Market by Country, 2018 - 2021, USD Million
TABLE 21 Europe Ceramic Market by Country, 2022 - 2028, USD Million
TABLE 22 Europe Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 23 Europe Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 24 Europe Chronic Pain Market by Country, 2018 - 2021, USD Million
TABLE 25 Europe Chronic Pain Market by Country, 2022 - 2028, USD Million
TABLE 26 Europe Urinary & Fecal Incontinence Market by Country, 2018 - 2021, USD Million
TABLE 27 Europe Urinary & Fecal Incontinence Market by Country, 2022 - 2028, USD Million
TABLE 28 Europe Migraine Market by Country, 2018 - 2021, USD Million
TABLE 29 Europe Migraine Market by Country, 2022 - 2028, USD Million
TABLE 30 Europe Failed Back Syndrome Market by Country, 2018 - 2021, USD Million
TABLE 31 Europe Failed Back Syndrome Market by Country, 2022 - 2028, USD Million
TABLE 32 Europe Parkinson Disease Market by Country, 2018 - 2021, USD Million
TABLE 33 Europe Parkinson Disease Market by Country, 2022 - 2028, USD Million
TABLE 34 Europe Epilepsy Market by Country, 2018 - 2021, USD Million
TABLE 35 Europe Epilepsy Market by Country, 2022 - 2028, USD Million
TABLE 36 Europe Tremor Market by Country, 2018 - 2021, USD Million
TABLE 37 Europe Tremor Market by Country, 2022 - 2028, USD Million
TABLE 38 Europe Depression Market by Country, 2018 - 2021, USD Million
TABLE 39 Europe Depression Market by Country, 2022 - 2028, USD Million
TABLE 40 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 41 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 42 Europe Neuromodulation Market by Country, 2018 - 2021, USD Million
TABLE 43 Europe Neuromodulation Market by Country, 2022 - 2028, USD Million
TABLE 44 Germany Neuromodulation Market, 2018 - 2021, USD Million
TABLE 45 Germany Neuromodulation Market, 2022 - 2028, USD Million
TABLE 46 Germany Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 47 Germany Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 48 Germany Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 49 Germany Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 50 Germany Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 51 Germany Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 52 UK Neuromodulation Market, 2018 - 2021, USD Million
TABLE 53 UK Neuromodulation Market, 2022 - 2028, USD Million
TABLE 54 UK Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 55 UK Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 56 UK Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 57 UK Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 58 UK Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 59 UK Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 60 France Neuromodulation Market, 2018 - 2021, USD Million
TABLE 61 France Neuromodulation Market, 2022 - 2028, USD Million
TABLE 62 France Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 63 France Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 64 France Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 65 France Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 66 France Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 67 France Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 68 Russia Neuromodulation Market, 2018 - 2021, USD Million
TABLE 69 Russia Neuromodulation Market, 2022 - 2028, USD Million
TABLE 70 Russia Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 71 Russia Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 72 Russia Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 73 Russia Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 74 Russia Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 75 Russia Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 76 Spain Neuromodulation Market, 2018 - 2021, USD Million
TABLE 77 Spain Neuromodulation Market, 2022 - 2028, USD Million
TABLE 78 Spain Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 79 Spain Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 80 Spain Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 81 Spain Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 82 Spain Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 83 Spain Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 84 Italy Neuromodulation Market, 2018 - 2021, USD Million
TABLE 85 Italy Neuromodulation Market, 2022 - 2028, USD Million
TABLE 86 Italy Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 87 Italy Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 88 Italy Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 89 Italy Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 90 Italy Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 91 Italy Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 92 Rest of Europe Neuromodulation Market, 2018 - 2021, USD Million
TABLE 93 Rest of Europe Neuromodulation Market, 2022 - 2028, USD Million
TABLE 94 Rest of Europe Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 95 Rest of Europe Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 96 Rest of Europe Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 97 Rest of Europe Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 98 Rest of Europe Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 99 Rest of Europe Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 100 Key Information – Medtronic PLC
TABLE 101 Key Information – LivaNova PLC
TABLE 102 key Information – Boston Scientific Corporation
TABLE 103 Key Information – Abbott Laboratories
TABLE 104 Key Information – Nevro Corporation
TABLE 105 key Information – NeuroSigma, Inc.
TABLE 106 Key Information – NeuroPace, Inc.
TABLE 107 Key Information – Neuronetics, Inc.
TABLE 108 Key Information – MicroTransponder Inc.
TABLE 109 Key Information – Bioventus Inc.

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Recent strategies and developments: Medtronic PLC
FIG 5 Recent strategies and developments: Bioventus Inc.